 DISARVAL
|
Baliarda
|
| valsartán+amlodipina |
Antihipertensivo |
| 160/10 mg comp.rec.x 30 | $48.774,65 | (17/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.907,65 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.555,31 AF $21.219,34 |
|
|
|
|
| 160/10 mg comp.rec.x 60 | $89.936,83 | (17/12/25) |
|
| 160/5 mg comp.rec.x 30 | $47.415,68 | (17/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.252,55 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $26.450,62 AF $20.965,06 |
|
|
|
|
| 160/5 mg comp.rec.x 60 | $86.596,42 | (17/12/25) |
|
| 320/10 mg comp.rec.x 30 | $62.945,07 | (17/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $23.542,85 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $36.831,33 AF $26.113,74 |
|
|
|
|
| 320/5 mg comp.rec.x 30 | $61.787,11 | (17/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $22.774,51 |
|
|
|
|
| |
